Altynai Satylganova

Soborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.

Journal: Lancet (London, England)

Published: April 01, 2021

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.

Journal: Lancet (London, England)

Published: February 26, 2021

Body mass index trajectories among people with obesity and association with mortality: Evidence from a large Israeli database.

Body mass index trajectories among people with obesity and association with mortality: Evidence from a large Israeli database.

Journal: Obesity science & practice

Published: October 08, 2020

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database.

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database.

Journal: International journal of obesity (2005)

Published: July 23, 2020

Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data.

Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data.

Journal: International journal of obesity (2005)

Published: July 15, 2020

Body mass index and risk of obesity-related conditions in a cohort of 2.9 million people: Evidence from a UK primary care database.

Body mass index and risk of obesity-related conditions in a cohort of 2.9 million people: Evidence from a UK primary care database.

Journal: Obesity science & practice

Published: June 03, 2020

Obesity, cardiovascular risk and healthcare resource utilization in the UK.

Obesity, cardiovascular risk and healthcare resource utilization in the UK.

Journal: European journal of preventive cardiology

Published: January 24, 2020

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial.

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial.

Journal: Diabetes care

Published: August 30, 2019

A comprehensive descriptive assessment of obesity related chronic morbidity and estimated annual cost burden from a population-based electronic health record database.

A comprehensive descriptive assessment of obesity related chronic morbidity and estimated annual cost burden from a population-based electronic health record database.

Journal: Israel journal of health policy research

Published: August 06, 2019

Prevalence of depression in adults with type 2 diabetes in the Basque Country: relationship with glycaemic control and health care costs.

Prevalence of depression in adults with type 2 diabetes in the Basque Country: relationship with glycaemic control and health care costs.

Journal: BMC public health

Published: February 03, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026